FDA Approves New Prostate Cancer Imaging Agent Gozellix®

Go back to FDA Approves New Prostate Cancer Imaging Agent Gozellix®
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.62 +0.17 (1.48%)
Previous Close $11.45    52 Week High $2.18 
Open $11.44    52 Week Low $0.30 
Day High $11.69    P/E N/A 
Day Low $11.35    EPS $-3.32 
Volume 850,950       

TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.62 +0.17 (1.48%)
Previous Close $11.45    52 Week High $2.18 
Open $11.44    52 Week Low $0.30 
Day High $11.69    P/E N/A 
Day Low $11.35    EPS $-3.32 
Volume 850,950